Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 5/2020

01.05.2020 | Original Article

Tumour and pelvic lymph node metabolic activity on FDG-PET/CT to stratify patients for para-aortic surgical staging in locally advanced cervical cancer

verfasst von: A. Martinez, M. Voglimacci, A. Lusque, A. Ducassou, L. Gladieff, N. Dupuis, M. A. Angeles, C. Martinez, Y. Tanguy Le Gac, E. Chantalat, A. Hitzel, F. Courbon, G. Ferron, E. Gabiache

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of our study was to comprehensively evaluate the most valuable metabolic parameters of cervical tumours and pelvic lymph nodes (PLN) by FDG-PET/CT to predict para-aortic lymph node (PALN) metastasis and stratify patients for surgical staging.

Methods

The study included patients with locally advanced cervical cancer, negative PALN uptake on preoperative FDG-PET/CT, and para-aortic lymphadenectomy. Two senior nuclear medicine physicians expert in gynaecologic oncology reviewed all PET/CT exams, and extracted tumour SUVmax, MTV, and TLG, as well as PLN. Prognostic parameters of PALN involvement were identified using ROC curves and logistic regression analysis.

Results

One hundred and twenty-five consecutive locally advanced cervical cancer patients were included. The FDG-PET/CT false-negative rate was, respectively, 27.7% (13/47) and 5.1% (4/78) in patients with and without FDG-PET/CT PLN uptake. The AUC of cervical tumour size, SUVmax, MTV, and TLG was, respectively, 0.75 (0.62–0.87), 0.59 (0.44–0.76), 0.75 (0.60–0.90), and 0.71 (0.56–0.86). The AUC of PLN size, SUVmax, SUVmean, PLN SUVmax/Tumour SUVmax ratio, MTV, and TLG was, respectively, 0.57 (0.37–0.78), 0.82 (0.68–0.95), 0.77 (0.61–0.94), 0.85 (0.72–0.98), 0.69 (0.51–0.87), and 0.74 (0.57–0.91). The metabolic parameter showing the best trade-off between sensitivity and specificity to predict PALN involvement was the ratio between PLN and tumour SUVmax.

Conclusion

The risk of PALN metastasis in FDG-PET/CT negative PLN patients is very low, so para-aortic lymphadenectomy does not seem justified. In patients with preoperative PLN uptake on FDG-PET/CT, surgical staging led to treatment modification in more than 25% of cases and should therefore be performed. Patients with more than one positive PLN and high PLN metabolic activity are at high risk of para-aortic extension and recurrence. Further prospective evaluation is required to consider intensified treatment modalities without prior PALN dissection.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Quinn M a, Benedet JL, Odicino F, Maisonneuve P, Beller U, Creasman WT, et al. Carcinoma of the cervix uteri. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet. 2006;95(Suppl 1):S43–103.CrossRef Quinn M a, Benedet JL, Odicino F, Maisonneuve P, Beller U, Creasman WT, et al. Carcinoma of the cervix uteri. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet. 2006;95(Suppl 1):S43–103.CrossRef
3.
Zurück zum Zitat Marth C, Landoni F, Mahner S, McCormack M, Gonzalez-Martin A, Colombo N. Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28:iv72–83.CrossRef Marth C, Landoni F, Mahner S, McCormack M, Gonzalez-Martin A, Colombo N. Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28:iv72–83.CrossRef
4.
Zurück zum Zitat Chuang LT, Temin S, Camacho R, Feldman S, Gultekin M, Gupta V, et al. Management and care of women with invasive cervical cancer: American Society of Clinical Oncology resource-stratified clinical practice guideline. J Glob Oncol. 2016;2:1–30.CrossRef Chuang LT, Temin S, Camacho R, Feldman S, Gultekin M, Gupta V, et al. Management and care of women with invasive cervical cancer: American Society of Clinical Oncology resource-stratified clinical practice guideline. J Glob Oncol. 2016;2:1–30.CrossRef
6.
Zurück zum Zitat Gouy S, Morice P, Narducci F, Uzan C, Gilmore J, Kolesnikov-Gauthier H, et al. Nodal-staging surgery for locally advanced cervical cancer in the era of PET. Lancet Oncol. 2012;13:e212–20.CrossRef Gouy S, Morice P, Narducci F, Uzan C, Gilmore J, Kolesnikov-Gauthier H, et al. Nodal-staging surgery for locally advanced cervical cancer in the era of PET. Lancet Oncol. 2012;13:e212–20.CrossRef
7.
Zurück zum Zitat Gouy S, Morice P, Narducci F, Uzan C, Martinez A, Rey A, et al. Prospective multicenter study evaluating the survival of patients with locally advanced cervical cancer undergoing laparoscopic para-aortic lymphadenectomy before chemoradiotherapy in the era of positron emission tomography imaging. J Clin Oncol. 2013;31:3026–33.CrossRef Gouy S, Morice P, Narducci F, Uzan C, Martinez A, Rey A, et al. Prospective multicenter study evaluating the survival of patients with locally advanced cervical cancer undergoing laparoscopic para-aortic lymphadenectomy before chemoradiotherapy in the era of positron emission tomography imaging. J Clin Oncol. 2013;31:3026–33.CrossRef
8.
Zurück zum Zitat Cibula D, Pötter R, Planchamp F, Avall-lundqvist E, Fischerova D, Haie C, et al. The European Society of Gynaecological Oncology / European Society for Radiotherapy and Oncology / European Society of Pathology guidelines for the management of patients with cervical cancer. Radiother Oncol. 2019;127:404–16 Available from: https://doi.org/10.1016/j.radonc.2018.03.003.CrossRef Cibula D, Pötter R, Planchamp F, Avall-lundqvist E, Fischerova D, Haie C, et al. The European Society of Gynaecological Oncology / European Society for Radiotherapy and Oncology / European Society of Pathology guidelines for the management of patients with cervical cancer. Radiother Oncol. 2019;127:404–16 Available from: https://​doi.​org/​10.​1016/​j.​radonc.​2018.​03.​003.CrossRef
10.
Zurück zum Zitat Kidd EA, Siegel BA, Dehdashti F. The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival. Cancer. 2007;110(8):1738–44. https://doi.org/10.1002/cncr.22974. Kidd EA, Siegel BA, Dehdashti F. The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival. Cancer. 2007;110(8):1738–44. https://​doi.​org/​10.​1002/​cncr.​22974.
11.
Zurück zum Zitat Sarker A, Im H-J, Cheon GJ, Chung HH, Kang KW, Chung J-K, et al. Prognostic implications of the SUVmax of primary tumors and metastatic lymph node measured by 18F-FDG PET in patients with uterine cervical cancer. A meta-analysis. Clin Nucl Med. 2016;41(1):34–40. https://doi.org/10.1097/RLU.0000000000001049. Sarker A, Im H-J, Cheon GJ, Chung HH, Kang KW, Chung J-K, et al. Prognostic implications of the SUVmax of primary tumors and metastatic lymph node measured by 18F-FDG PET in patients with uterine cervical cancer. A meta-analysis. Clin Nucl Med. 2016;41(1):34–40. https://​doi.​org/​10.​1097/​RLU.​0000000000001049​.
12.
Zurück zum Zitat Voglimacci M, Gabiache E, Lusque A, Ferron G, Ducassou A, Querleu D, et al. Chemoradiotherapy for locally advanced cervix cancer without aortic lymph node involvement : can we consider metabolic parameters of pretherapeutic FDG-PET / CT for treatment tailoring ? Eur J Nucl Med Mol Imaging. 2019;46(7):1551–9. https://doi.org/10.1007/s00259-018-4219-5. Voglimacci M, Gabiache E, Lusque A, Ferron G, Ducassou A, Querleu D, et al. Chemoradiotherapy for locally advanced cervix cancer without aortic lymph node involvement : can we consider metabolic parameters of pretherapeutic FDG-PET / CT for treatment tailoring ? Eur J Nucl Med Mol Imaging. 2019;46(7):1551–9. https://​doi.​org/​10.​1007/​s00259-018-4219-5.
13.
Zurück zum Zitat Onal C, Reyhan M, Parlak C, Guler OC, Oymak E. Prognostic value of pretreatment F-18-fluorodeoxyglucose uptake in patients with cervical cancer treated with definitive chemoradiotherapy. Int J Gynecol Cancer. 2013;23:1104–10.CrossRef Onal C, Reyhan M, Parlak C, Guler OC, Oymak E. Prognostic value of pretreatment F-18-fluorodeoxyglucose uptake in patients with cervical cancer treated with definitive chemoradiotherapy. Int J Gynecol Cancer. 2013;23:1104–10.CrossRef
14.
Zurück zum Zitat Vural GU, Akkas BE, Demirel BB. Standardized uptake value and metabolic tumor volume measured by 18 F FDG PET / CT are sensitive biomarkers for the presence of lymph node metastasis in patients with cervical carcinoma. Rev Esp Med Nucl Imagen Mol. 2014;33:268–73.PubMed Vural GU, Akkas BE, Demirel BB. Standardized uptake value and metabolic tumor volume measured by 18 F FDG PET / CT are sensitive biomarkers for the presence of lymph node metastasis in patients with cervical carcinoma. Rev Esp Med Nucl Imagen Mol. 2014;33:268–73.PubMed
15.
Zurück zum Zitat Kidd EA, Siegel BA, Dehdashti F, Grigsby PW. Pelvic lymph node F-18 fluorodeoxyglucose uptake as a prognostic biomarker in newly diagnosed patients with locally advanced cervical cancer. 2010;116(6):1469–1475. https://doi.org/10.1002/cncr.24972. Kidd EA, Siegel BA, Dehdashti F, Grigsby PW. Pelvic lymph node F-18 fluorodeoxyglucose uptake as a prognostic biomarker in newly diagnosed patients with locally advanced cervical cancer. 2010;116(6):1469–1475. https://​doi.​org/​10.​1002/​cncr.​24972.
16.
Zurück zum Zitat Onal C, Guler OC, Reyhan M, Fuat A. Prognostic value of 18 F-fluorodeoxyglucose uptake in pelvic lymph nodes in patients with cervical cancer treated with definitive chemoradiotherapy. Gynecol Oncol. 2015;137:40–6.CrossRef Onal C, Guler OC, Reyhan M, Fuat A. Prognostic value of 18 F-fluorodeoxyglucose uptake in pelvic lymph nodes in patients with cervical cancer treated with definitive chemoradiotherapy. Gynecol Oncol. 2015;137:40–6.CrossRef
17.
Zurück zum Zitat Chung HH, Cheon GJ, Kang KW, Kim JW, Park N-H, Song YS. Preoperative PET / CT FDG standardized uptake value of pelvic lymph nodes as a significant prognostic factor in patients with uterine cervical cancer. Eur J Nucl Med Mol Imaging. 2014;41(4):674–81. Chung HH, Cheon GJ, Kang KW, Kim JW, Park N-H, Song YS. Preoperative PET / CT FDG standardized uptake value of pelvic lymph nodes as a significant prognostic factor in patients with uterine cervical cancer. Eur J Nucl Med Mol Imaging. 2014;41(4):674–81.
18.
Zurück zum Zitat Sonoda Y, Leblanc E, Querleu D, Castelain B, Papageorgiou TH, Lambaudie E, et al. Prospective evaluation of surgical staging of advanced cervical cancer via a laparoscopic extraperitoneal approach. Gynecol Oncol. 2003;91:326–31.CrossRef Sonoda Y, Leblanc E, Querleu D, Castelain B, Papageorgiou TH, Lambaudie E, et al. Prospective evaluation of surgical staging of advanced cervical cancer via a laparoscopic extraperitoneal approach. Gynecol Oncol. 2003;91:326–31.CrossRef
19.
Zurück zum Zitat Boellaard R, Delgado-Bolton R, Oyen WJG, Giammarile F, Tatsch K, Eschner W, et al. FDG PET / CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328–54.CrossRef Boellaard R, Delgado-Bolton R, Oyen WJG, Giammarile F, Tatsch K, Eschner W, et al. FDG PET / CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328–54.CrossRef
20.
Zurück zum Zitat Gold MA, Tian C, Whitney CW, Rose PG, Lanciano R. Surgical versus radiographic determination of para-aortic lymph node metastases before chemoradiation for locally advanced cervical carcinoma. Cancer. 2008;112(9):1954–63. https://doi.org/10.1002/cncr.23400. Gold MA, Tian C, Whitney CW, Rose PG, Lanciano R. Surgical versus radiographic determination of para-aortic lymph node metastases before chemoradiation for locally advanced cervical carcinoma. Cancer. 2008;112(9):1954–63. https://​doi.​org/​10.​1002/​cncr.​23400.
21.
Zurück zum Zitat Havrilesky LJ, Kulasingam SL, Matchar DB, Myers ER. FDG-PET for management of cervical and ovarian cancer. Gynecol Oncol. 2005;97:183–91.CrossRef Havrilesky LJ, Kulasingam SL, Matchar DB, Myers ER. FDG-PET for management of cervical and ovarian cancer. Gynecol Oncol. 2005;97:183–91.CrossRef
22.
Zurück zum Zitat Marth C, Landoni F, Mahner S, McCormack M, Gonzalez-Martin A, Colombo N. Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28:iv72–83.CrossRef Marth C, Landoni F, Mahner S, McCormack M, Gonzalez-Martin A, Colombo N. Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28:iv72–83.CrossRef
23.
Zurück zum Zitat Leblanc E, Gauthier H, Querleu D, Ferron G, Zerdoud S, Morice P, et al. Accuracy of 18-Fluoro-2-deoxy-d-glucose positron emission tomography in the pretherapeutic detection of occult para-aortic node involvement in patients with a locally advanced cervical carcinoma. Ann Surg Oncol. 2011;18:2302–9.CrossRef Leblanc E, Gauthier H, Querleu D, Ferron G, Zerdoud S, Morice P, et al. Accuracy of 18-Fluoro-2-deoxy-d-glucose positron emission tomography in the pretherapeutic detection of occult para-aortic node involvement in patients with a locally advanced cervical carcinoma. Ann Surg Oncol. 2011;18:2302–9.CrossRef
24.
Zurück zum Zitat Gouy S, Morice P, Narducci F, Uzan C, Martinez A, Rey A, et al. Prospective multicenter study evaluating the survival of patients with locally advanced cervical cancer undergoing laparoscopic para-aortic lymphadenectomy before chemoradiotherapy in the era of positron emission tomography. J Clin Oncol. 2013;31(24):3026–33. https://doi.org/10.1200/JCO.2012.47.3520. Gouy S, Morice P, Narducci F, Uzan C, Martinez A, Rey A, et al. Prospective multicenter study evaluating the survival of patients with locally advanced cervical cancer undergoing laparoscopic para-aortic lymphadenectomy before chemoradiotherapy in the era of positron emission tomography. J Clin Oncol. 2013;31(24):3026–33. https://​doi.​org/​10.​1200/​JCO.​2012.​47.​3520.
26.
Zurück zum Zitat Imaging PPPET, Leblanc E, Katdare N, Narducci F, Bresson L, Gouy S, et al. Should Systematic Infrarenal Para-aortic Dissection Be the Rule in the Pretherapeutic Staging of Primary or Recurrent Locally Advanced Cervix Cancer Patients With a Negative Preoperative Para-aortic PET Imaging?. Int J Gynecol Cancer. 2016;26:169–75.CrossRef Imaging PPPET, Leblanc E, Katdare N, Narducci F, Bresson L, Gouy S, et al. Should Systematic Infrarenal Para-aortic Dissection Be the Rule in the Pretherapeutic Staging of Primary or Recurrent Locally Advanced Cervix Cancer Patients With a Negative Preoperative Para-aortic PET Imaging?. Int J Gynecol Cancer. 2016;26:169–75.CrossRef
27.
Zurück zum Zitat Han X, Wen H, Ju X, Chen X, Ke G. Predictive factors of para-aortic lymph nodes metastasis in cervical cancer patients: a retrospective analysis based on 723 para-aortic lymphadenectomy cases. Onctarget. 2017;8:51840–7. Han X, Wen H, Ju X, Chen X, Ke G. Predictive factors of para-aortic lymph nodes metastasis in cervical cancer patients: a retrospective analysis based on 723 para-aortic lymphadenectomy cases. Onctarget. 2017;8:51840–7.
31.
Zurück zum Zitat Brunette LL, Bonyadlou S, Ji L, Groshen S, Shuster D, Mehta A, et al. Predictive value of FDG PET / CT to detect lymph node metastases in cervical cancer. Clin Nucl Med. 2018;43:793–801.CrossRef Brunette LL, Bonyadlou S, Ji L, Groshen S, Shuster D, Mehta A, et al. Predictive value of FDG PET / CT to detect lymph node metastases in cervical cancer. Clin Nucl Med. 2018;43:793–801.CrossRef
34.
35.
Zurück zum Zitat Lai C, Huang K, Hong J, Lee C, Chou H, Chang T, et al. Randomized trial of surgical staging ( extraperitoneal or laparoscopic ) versus clinical staging in locally advanced cervical cancer. Gynecol Oncol. 2003;89:160–7.CrossRef Lai C, Huang K, Hong J, Lee C, Chou H, Chang T, et al. Randomized trial of surgical staging ( extraperitoneal or laparoscopic ) versus clinical staging in locally advanced cervical cancer. Gynecol Oncol. 2003;89:160–7.CrossRef
37.
Zurück zum Zitat Manders DB, Sims TT, Bailey A, Hwang L, Richardson DL, Miller DS, et al. The Significance of Para-Aortic Nodal Size and the Sole of Adjuvant Systemic Chemotherapy in Cervical Cancer: An Institutional Experience. Am J Clin Oncol. 2018;41:1225–30.CrossRef Manders DB, Sims TT, Bailey A, Hwang L, Richardson DL, Miller DS, et al. The Significance of Para-Aortic Nodal Size and the Sole of Adjuvant Systemic Chemotherapy in Cervical Cancer: An Institutional Experience. Am J Clin Oncol. 2018;41:1225–30.CrossRef
38.
Zurück zum Zitat Sapienza LG, Fernando V, Jr MML, Baiocchi G, Janeiro D, Sloan M, et al. HHS Public Access 2018;144:312–7. Sapienza LG, Fernando V, Jr MML, Baiocchi G, Janeiro D, Sloan M, et al. HHS Public Access 2018;144:312–7.
39.
Zurück zum Zitat Duen A. Phase III, Open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to. J Clin Oncol. 2019;29(13):1678–85. https://doi.org/10.1200/JCO.2009.25.9663. Duen A. Phase III, Open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to. J Clin Oncol. 2019;29(13):1678–85. https://​doi.​org/​10.​1200/​JCO.​2009.​25.​9663.
Metadaten
Titel
Tumour and pelvic lymph node metabolic activity on FDG-PET/CT to stratify patients for para-aortic surgical staging in locally advanced cervical cancer
verfasst von
A. Martinez
M. Voglimacci
A. Lusque
A. Ducassou
L. Gladieff
N. Dupuis
M. A. Angeles
C. Martinez
Y. Tanguy Le Gac
E. Chantalat
A. Hitzel
F. Courbon
G. Ferron
E. Gabiache
Publikationsdatum
01.05.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 5/2020
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-019-04659-z

Weitere Artikel der Ausgabe 5/2020

European Journal of Nuclear Medicine and Molecular Imaging 5/2020 Zur Ausgabe